Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2012 Apr 28

PMID 22537432

Citations 1520

Authors

Hashem B El-Serag

Affiliations

Soon will be listed here.

Abstract

Most cases of hepatocellular carcinoma (HCC) are associated with cirrhosis related to chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Changes in the time trends of HCC and most variations in its age-, sex-, and race-specific rates among different regions are likely to be related to differences in hepatitis viruses that are most prevalent in a population, the timing of their spread, and the ages of the individuals the viruses infect. Environmental, host genetic, and viral factors can affect the risk of HCC in individuals with HBV or HCV infection. This review summarizes the risk factors for HCC among HBV- or HCV-infected individuals, based on findings from epidemiologic studies and meta-analyses, as well as determinants of patient outcome and the HCC disease burden, globally and in the United States.

Citing Articles

Fluorescence-guided Surgery for Hepatocellular Carcinoma: From Clinical Practice to Laboratories.

Xiao T, Chen D, Peng L, Li Z, Pan W, Dong Y J Clin Transl Hepatol. 2025; 13(3):216-232.

PMID: 40078203 PMC: 11894393. DOI: 10.14218/JCTH.2024.00375.

Creation of an innovative diagnostic framework for hepatocellular carcinoma employing bioinformatics techniques focused on senescence-related and pyroptosis-related genes.

Liu B, Ao Y, Liu C, Bai F, Zhou Z, Huang J Front Oncol. 2025; 15:1485421.

PMID: 40018411 PMC: 11864952. DOI: 10.3389/fonc.2025.1485421.

Clinical Characteristics of Hepatitis B Virus-Associated Hepatocellular Carcinoma Patients in Southwest Nigeria.

Nwude V, Lesi O, Onyekwere C, Charpentier E, Hubschen J Pathogens. 2025; 14(2).

PMID: 40005544 PMC: 11858220. DOI: 10.3390/pathogens14020169.

Hepatocellular carcinoma recurrence: Predictors and management.

Abdelhamed W, El-Kassas M Liver Res. 2025; 7(4):321-332.

PMID: 39958776 PMC: 11791921. DOI: 10.1016/j.livres.2023.11.004.

Pan-serological antibodies and liver cancer risk: a nested case-control analysis.

Watling C, Hua X, Petrick J, Zhang X, Do W, Wang L Sci Rep. 2025; 15(1):5450.

PMID: 39953193 PMC: 11828989. DOI: 10.1038/s41598-025-89629-2.

References

Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A . Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002; 155(4):323-31. DOI: 10.1093/aje/155.4.323. View

Yang J, Kim W, Coelho R, Mettler T, Benson J, Sanderson S . Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2010; 9(1):64-70. PMC: 3951426. DOI: 10.1016/j.cgh.2010.08.019. View

Tanaka Y, Kurbanov F, Mano S, Orito E, Vargas V, Esteban J . Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology. 2006; 130(3):703-14. DOI: 10.1053/j.gastro.2006.01.032. View

Yang H, Lu S, Liaw Y, You S, Sun C, Wang L . Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002; 347(3):168-74. DOI: 10.1056/NEJMoa013215. View

Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E . Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology. 2007; 46(2):430-5. DOI: 10.1002/hep.21708. View

Liaw Y, Sung J, Chow W, Farrell G, Lee C, Yuen H . Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004; 351(15):1521-31. DOI: 10.1056/NEJMoa033364. View

Fattovich G, Bortolotti F, Donato F . Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2007; 48(2):335-52. DOI: 10.1016/j.jhep.2007.11.011. View

Donato F, Boffetta P, Puoti M . A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer. 1998; 75(3):347-54. DOI: 10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2. View

Yuan J, Ross R, Stanczyk F, Govindarajan S, Gao Y, Henderson B . A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China. Int J Cancer. 1995; 63(4):491-3. DOI: 10.1002/ijc.2910630405. View

10.

Haydon G, Jarvis L, Simmonds P, Hayes P . Association between chronic hepatitis C infection and hepatocellular carcinoma. Lancet. 1995; 345(8954):928-9. DOI: 10.1016/s0140-6736(95)90045-4. View

11.

Kao J, Chen P, Lai M, Chen D . Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology. 2003; 124(2):327-34. DOI: 10.1053/gast.2003.50053. View

12.

Kramer J, Giordano T, El-Serag H . Effect of human immunodeficiency virus and antiretrovirals on outcomes of hepatitis C: a systematic review from an epidemiologic perspective. Clin Gastroenterol Hepatol. 2007; 5(11):1321-1328.e7. DOI: 10.1016/j.cgh.2007.08.006. View

13.

Yeh S, Chen P . Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology. 2010; 78 Suppl 1:172-9. DOI: 10.1159/000315247. View

14.

Garner R, Miller E, Miller J . Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. Cancer Res. 1972; 32(10):2058-66. View

15.

El-Serag H, Hampel H, Javadi F . The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006; 4(3):369-80. DOI: 10.1016/j.cgh.2005.12.007. View

16.

De Mitri M, Poussin K, Baccarini P, Pontisso P, DErrico A, Simon N . HCV-associated liver cancer without cirrhosis. Lancet. 1995; 345(8947):413-5. DOI: 10.1016/s0140-6736(95)90400-x. View

17.

Chiu C, Yeh S, Chen P, Kuo T, Chang C, Chen P . Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci U S A. 2007; 104(8):2571-8. PMC: 1783528. DOI: 10.1073/pnas.0609498104. View

18.

Tong M, Lai L . Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy. West J Med. 1997; 167(2):103-5. PMC: 1304438. View

19.

Ni Y, Chang M, Wang K, Hsu H, Chen H, Kao J . Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 2004; 127(6):1733-8. DOI: 10.1053/j.gastro.2004.09.048. View

20.

Jee S, Ohrr H, Sull J, Samet J . Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst. 2004; 96(24):1851-6. DOI: 10.1093/jnci/djh334. View